Ratings by RBC Capital (Dan Leonard)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/11/2026 | Guardant Health | GH | New Coverage | Outperform (N/A) |
130.70 (133.60) |
2.22% | Details | |
| 6/11/2026 | Natera | NTRA | New Coverage | Outperform (N/A) |
216.50 (238.74) |
10.27% | Details | |
| 5/28/2026 | Agilent | A | Maintain | Outperform (N/A) |
|
Details | ||
| 5/26/2026 | Agilent | A | New Coverage | Outperform (N/A) |
114.96 (127.18) |
10.63% | Details | |
| 5/14/2026 | Bio-Rad Labs | BIO | New Coverage | Outperform (N/A) |
243.51 (275.24) |
13.03% | Details | |
| 5/14/2026 | Avantor Inc. | AVTR | New Coverage | Sector Perform (N/A) |
7.87 (9.17) |
16.52% | Details | |
| 5/14/2026 | Repligen | RGEN | New Coverage | Outperform (N/A) |
107.03 (125.38) |
17.14% | Details | |
| 5/14/2026 | Danaher | DHR | New Coverage | Outperform (N/A) |
165.99 (177.81) |
7.12% | Details | |
| 5/14/2026 | Illumina | ILMN | New Coverage | Outperform (N/A) |
145.00 (164.88) |
13.71% | Details | |
| 5/14/2026 | Thermo Fisher Scientific | TMO | New Coverage | Sector Perform (N/A) |
446.03 (466.06) |
4.49% | Details | |
| 5/14/2026 | Bio-Techne Corp. | TECH | New Coverage | Outperform (N/A) |
44.89 (56.52) |
25.91% | Details |
